| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2004;35:2879.)
© 2004 American Heart Association, Inc.
Original Contributions |
From the Stroke Center and Department of Neurology (B.O., J.L.S., A.F., S.S., S.Se., V.R., T.R., C.S.K.), UCLA Medical Center; Department of Neurology (B.O., J.L.S., A.F., S.S., S.Se., V.r., C.S.K.), Olive ViewUCLA Medical Center; and the Department of Nursing (N.M.), UCLA Medical Center, Los Angeles, Calif.
Correspondence to Dr Bruce Ovbiagele, Stroke Center and Department of Neurology, University of California at Los Angeles, 710 Westwood Plaza, Los Angeles, CA 90095, E-mail Ovibes{at}mednet.ucla.edu
Background and Purpose The Stroke PROTECT (Preventing Recurrence Of Thromboembolic Events through Coordinated Treatment) program systematically implements, at the time of acute transient ischemic attack (TIA) or ischemic stroke admission, 8 medication/behavioral secondary prevention measures known to improve outcome in patients with cerebrovascular disease. The objective of this study was to determine if the high utilization rates previously demonstrated at hospital discharge were maintained at 90 days after discharge.
Methods Data were prospectively collected on consecutively encountered ischemic stroke and TIA patients admitted to a university hospital stroke service beginning September 1, 2002. PROTECT interventions were initiated before hospital discharge in all PROTECTtarget (underlying stroke mechanism large vessel atherosclerosis or small vessel disease) and PROTECTACS (At-risk for Coronary Sequelae) patients. Adherence to program goals was assessed 3 months after discharge.
Results During the period from September 2002 to August 2003, 144 individuals met criteria for PROTECT intervention. Of the 130 patients (90%) with available day 90 follow-up data, mean age was 72 (range, 37 to 95), and 63% were male. Adherence rates in patients without specific contraindications were 100% for antithrombotics, 99% for statins, 92% for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and 80% for thiazides. Awareness of the importance of calling 911 in response to stroke was 87%. Adherence to diet and exercise guidelines were 78% and 70%, respectively. Of the 24 smokers, tobacco cessation was maintained in 20 (83%).
Conclusions High rates of adherence to PROTECT therapies were maintained at 90 days after hospital discharge.
Key Words: atherosclerosis stroke management stroke prevention
This article has been cited by other articles:
![]() |
E. Touze, J. Coste, M. Voicu, J. Kansao, R. Masmoudi, B. Doumenc, P. Durieux, and J.-L. Mas Importance of In-Hospital Initiation of Therapies and Therapeutic Inertia in Secondary Stroke Prevention: IMplementation of Prevention After a Cerebrovascular evenT (IMPACT) Study Stroke, June 1, 2008; 39(6): 1834 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ovbiagele, O. Drogan, W. J. Koroshetz, P. Fayad, and J. L. Saver Outpatient Practice Patterns After Stroke Hospitalization Among Neurologists Stroke, June 1, 2008; 39(6): 1850 - 1854. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Suarez and T. A. Kent The time is right to improve organization of stroke care Neurology, April 8, 2008; 70(15): 1232 - 1233. [Full Text] [PDF] |
||||
![]() |
S. A. Josephson, S. Sidney, T. N. Pham, A. L. Bernstein, and S. C. Johnston Factors Associated With the Decision to Hospitalize Patients After Transient Ischemic Attack Before Publication of Prediction Rules Stroke, February 1, 2008; 39(2): 411 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Ramsay, P. H. Whincup, S. G. Wannamethee, O. Papacosta, L. Lennon, M. C. Thomas, and R. W. Morris Missed opportunities for secondary prevention of cerebrovascular disease in elderly British men from 1999 to 2005: a population-based study J. Public Health Med., September 1, 2007; 29(3): 251 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Redfern, C. McKevitt, and C. D.A. Wolfe Development of Complex Interventions in Stroke Care: A Systematic Review Stroke, September 1, 2006; 37(9): 2410 - 2419. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Kent Stroke -- An Equal Opportunity for the Initiation of Statin Therapy N. Engl. J. Med., August 10, 2006; 355(6): 613 - 615. [Full Text] [PDF] |
||||
![]() |
M. S.V. Elkind and C. G. Benesch Lowering cholesterol in patients with stroke: Raising the standard Neurology, April 25, 2006; 66(8): 1140 - 1141. [Full Text] [PDF] |
||||
![]() |
B. Ovbiagele, J. L. Saver, H. Bang, L. E. Chambless, A. Nassief, J. Minuk, J. F. Toole, J. R. Crouse, and for the VISP Study Investigators Statin treatment and adherence to national cholesterol guidelines after ischemic stroke Neurology, April 25, 2006; 66(8): 1164 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Donnan, S. M. Davis, M. D. Hill, and D. J. Gladstone Patients With Transient Ischemic Attack or Minor Stroke Should Be Admitted to Hospital: For Stroke, April 1, 2006; 37(4): 1137 - 1138. [Full Text] [PDF] |
||||
![]() |
B. Norrving and R. J. Adams Organized Stroke Care Stroke, February 1, 2006; 37(2): 326 - 328. [Full Text] [PDF] |
||||
![]() |
M. N. Nguyen-Huynh and S. C. Johnston Is hospitalization after TIA cost-effective on the basis of treatment with tPA? Neurology, December 13, 2005; 65(11): 1799 - 1801. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ovbiagele, N. K. Hills, J. L. Saver, and S. C. Johnston Antihypertensive Medications Prescribed at Discharge After an Acute Ischemic Cerebrovascular Event Stroke, September 1, 2005; 36(9): 1944 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moonis, K. Kane, U. Schwiderski, B. W. Sandage, and M. Fisher HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke Outcome Stroke, June 1, 2005; 36(6): 1298 - 1300. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |